Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Can-Fite BioPharma Ltd.

    AMEX: CANF · Real-Time Price · USD
    0.68
    0.02 (2.77%)
    At close: Aug 18, 2025, 11:47 AM

    Can-Fite BioPharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Net Income
    		 -7.88M -7.57M -7.37M -7.06M -7.63M -9M -9.77M -10.29M -10.17M -11.27M -12.14M -13.17M -12.62M -12.13M -11.3M -11.98M
    Depreciation & Amortization
    		 7K 4K 1K 500.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Stock-Based Compensation
    		 362K 538.5K 359K 357.5K 261K 263K 223K 263K 263K 466K 367K 466K 466K 355K 490K 355K
    Other Working Capital
    		 -109K -376.5K -644K -322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Non-Cash Items
    		 -17K 1.57M 3.62M 5.01M 7.37M 8.74M 9.54M 10.03M 9.91M 10.81M 11.78M 12.71M 12.15M 11.78M 10.81M 11.62M
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 -109K -376.5K -644K -322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Cash Flow
    		 -7.64M -5.84M -4.13M -2.02M n/a 263K 223K 263K 263K n/a 135K n/a n/a n/a n/a n/a
    Capital Expenditures
    		 -5K -4.5K -4K -2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 1.5M 3M 4.5M 2.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 1.5M 3M 4.5M 2.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 6.71M 3.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Financial Cash Flow
    		 6.71M 3.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Net Cash Flow
    		 n/a n/a -95K n/a n/a 263K 223K 263K 263K n/a 135K n/a n/a n/a n/a n/a
    Free Cash Flow
    		 -7.64M -5.84M -4.13M -2.02M n/a 263K 223K 263K 263K n/a 135K n/a n/a n/a n/a n/a

    Add to Watchlist